Targeting AML with Multi-Antigen Specific T Cells Engineered to Express a CAR Specific for SSX2 Peptide 41-49

被引:0
|
作者
Pezzella, Gloria [1 ]
Achour, Achouak [1 ]
Yvon, Eric S. [2 ]
Bollard, Catherine M. [1 ,2 ]
Toner, Keri [1 ,2 ]
机构
[1] Childrens Natl Hosp, Washington, DC USA
[2] George Washington Univ, Washington, DC USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
142
引用
收藏
页码:77 / 78
页数:2
相关论文
共 50 条
  • [21] Novel TCR-like CAR-T cells targeting an HLA*0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia
    Raskin, Scott
    Van Pelt, Stacey
    Toner, Keri
    Balakrishnan, Preethi Bala
    Dave, Hema
    Bollard, Catherine M.
    Yvon, Eric
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 296 - 306
  • [22] B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo
    Kosiewicz, MM
    Krishnan, A
    Worthington, MT
    Matriano, JA
    Ross, WG
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (06) : 1679 - 1687
  • [23] EphA2 specific chimeric antigen receptor engineered T cells for the treatment of prostate cancer
    Zhang, Miaomiao
    Wang, Haiting
    Wang, Meng
    Zhang, Haoliang
    Li, Huizhong
    Ma, Ping
    Zheng, Junnian
    Wang, Gang
    Li, Shibao
    TRANSLATIONAL ONCOLOGY, 2024, 50
  • [24] CCTx-001 CAR T-cells targeting the AML specific antigen IL-1RAP show robust preclinical anti-tumor efficacy
    De Dreuzy, Edouard
    El Sayed, Soha Reda
    Genin, Delphine
    Primus, Clementine
    Bouquet, Lucie
    Collette, Alexis
    Favre-Bulle, Olivier
    Rutjens, Erik
    Hasskarl, Jens
    Pavletic, Ksenija
    Deschamps, Marina
    Ferrand, Christophe
    Sainson, Richard C. A.
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
    Li, S.
    Yang, J.
    Urban, F. A.
    MacGregor, J. N.
    Hughes, D. P. M.
    Chang, A. E.
    Mcdonagh, K. T.
    Li, Q.
    CANCER GENE THERAPY, 2008, 15 (06) : 382 - 392
  • [26] Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
    S Li
    J Yang
    F A Urban
    J N MacGregor
    D P M Hughes
    A E Chang
    K T Mcdonagh
    Q Li
    Cancer Gene Therapy, 2008, 15 : 382 - 392
  • [27] PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma
    Martinez Bedoya, Darel
    Marinari, Eliana
    Davanture, Suzel
    Castillo Cantero, Luis
    Erraiss, Sarah
    Dockerill, Millicent
    Barluenga, Sofia
    Winssinger, Nicolas
    Schaller, Karl
    Bijlenga, Philippe
    Momjian, Shahan
    Voize, Christel
    Tissot, Stephanie R.
    Kandalaft, Lana E.
    Hammel, Philippe
    Cosson, Pierre
    Walker, Paul R.
    Dutoit, Valerie
    Migliorini, Denis
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (12) : 1718 - 1735
  • [28] Therapy targeting antigen-specific T cells by a peptide-based tolerizing vaccine against autoimmune arthritis
    Urbonaviciute, Vilma
    Romero-Castillo, Laura
    Xu, Bingze
    Luo, Huqiao
    Schneider, Nadine
    Weisse, Sylvia
    Do, Nhu-Nguyen
    Oliveira-Coelho, Ana
    Lahore, Gonzalo Fernandez
    Li, Taotao
    Sabatier, Pierre
    Beusch, Christian M.
    Viljanen, Johan
    Zubarev, Roman A.
    Kihlberg, Jan
    Baecklund, Johan
    Burkhardt, Harald
    Holmdahl, Rikard
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (25)
  • [29] Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo
    Mahnke, K
    Qian, YJ
    Knop, J
    Enk, AH
    NATURE BIOTECHNOLOGY, 2003, 21 (08) : 903 - 908
  • [30] Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo
    Karsten Mahnke
    Yingjie Qian
    Jürgen Knop
    Alexander H Enk
    Nature Biotechnology, 2003, 21 : 903 - 908